LFM A13

• Background :

  LFM A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK).

• Description :

  BTK kinase inhibitor

• Product Name Alternative :

  2-Cyano-N- (2,5-dibromophenyl) -3-hydroxy-2-butenamide

• UNSPSC :

  41116105

• Type :

  Inhibitor

• Source :

  Synthetic

• Field of Research :

  Cell Signaling | Cancer | Apoptosis | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors

• Purity :

  ≥97% (TLC)

• Weight :

  0.025

• Format :

  Yellow solid

• Solubility :

  Soluble in DMSO (10 mg/ml) or ethanol (0.3 mg/ml)

• Molecular Formula :

  C11H8Br2N2O2

• Molecular Weight :

  360

• Precautions :

  Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• References & Citations :

  1. Vassilev A., Ozer Z., Navara C., Mahajan S., & Uckun F.M. (1999). J. Biol. Chem. 274(3): 1646–1656.

• CAS Number :

  62004-35-7